TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ekman Biomedical Data AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
655
|
258
|
61 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-194
|
95
|
-1 |
| EBITDA |
-208
|
83
|
-1 |
| Total assets |
729
|
836
|
693 |
| Current assets |
729
|
836
|
693 |
| Current liabilities |
189
|
77
|
13 |
| Equity capital |
540
|
759
|
680 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
0
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.1%
|
90.8%
|
98.1% |
| Turnover per employee | 655 | 61 | |
| Profit as a percentage of turnover |
-29.6%
|
36.8%
|
-1.6% |
| Return on assets (ROA) |
-26.6%
|
11.4%
|
-0.1% |
| Current ratio |
385.7%
|
1085.7%
|
5330.8% |
| Return on equity (ROE) |
-35.9%
|
12.5%
|
-0.1% |
| Change turnover |
405
|
197
|
36 |
| Change turnover % |
163%
|
322%
|
146% |
| Chg. No. of employees |
1
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.